Early acyclovir for herpes in ventilated patients
Part of Infections, Lungs & breathing clinical trials.
This trial tests whether giving the antiviral drug acyclovir early can help people on ventilators who show signs of herpes virus in the throat. The goal is to reduce complications and improve recovery.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 or older.
- You have been on a breathing tube (ventilator) for at least 4 days and likely need it for at least 2 more days.
- A throat swab showed herpes simplex virus (HSV) in your throat.
- You have no more than one organ that is failing (like kidneys, lungs, or heart).
- You have not taken antiviral medicine in the last 30 days, and you are not severely immunocompromised.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether acyclovir, an antiviral drug, can help patients with pneumonia who are on breathing support and have herpes simplex virus in their lung fluid. The goal is to see if it improves recovery.
This study tests whether taking an antiviral medicine (aciclovir) by mouth can help people recover from meningitis caused by the herpes simplex virus type 2 (HSV-2). You would receive either the active medicine or a placebo (a pill with no active ingredient) to see if it improves recovery.
This study checks how acyclovir behaves in the body when it’s given by mouth or through an IV to children receiving cancer care. It may help doctors better choose doses and monitor the medicine in kids who need prevention or treatment of certain viral infections.
This trial offers a new antiviral medicine called pritelivir to people with weakened immune systems who have herpes sores that do not get better with standard treatments. Taking pritelivir may help clear these resistant sores when other options have failed.
This study looks at how a common virus, herpes simplex virus type 1 (the one that causes cold sores), may reactivate in people with severe pneumonia in the ICU. The goal is to understand this better, which could help with future treatments.
This trial tests whether a medicine called acyclovir can prevent herpes simplex outbreaks in people who also have an autoimmune rheumatic disease. It may help reduce the number of painful cold sores or genital herpes episodes you experience.
Hear when a new Invasive Mechanical Ventilation trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.